Already a Bloomberg.com user?
Sign in with the same account.
Oct. 11 (Bloomberg) -- SymBio Pharmaceuticals Ltd. will sell shares for 560 yen each in an initial public offering, according to a statement today on the company’s website.
The Tokyo-based drug developer will list its shares on the Osaka Securities Exchange’s Jasdaq Growth market on Oct. 20.
To contact the editor responsible for this story: Taku Kato at firstname.lastname@example.org